{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:55:32Z","timestamp":1790870132100,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI171954"],"award-info":[{"award-number":["U19AI171954"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI195592"],"award-info":[{"award-number":["R01AI195592"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Ebola virus (EBOV) causes outbreaks with high fatality rates, yet potent small-molecule inhibitors targeting EBOV glycoprotein (GP) remain limited. Here, using DNA-encoded chemical libraries, we screen 4.73 billion compounds against EBOV GP and, through stereochemical optimization, identify MWAC-3634. This compound binds GP with high affinity (K\n                    <jats:sub>d<\/jats:sub>\n                    =40.7\u2009nM), potently neutralizes infection (IC\u2085\u2080\u2009=\u20090.65\u2009nM), shows no detectable cytotoxicity, and exhibits favorable pharmacokinetics in mice. This potency substantially exceeds that of known small-molecule inhibitors targeting EBOV GP. Cryo-EM at 2.54\u2009\u00c5 resolution reveals that MWAC-3634 occupies a hydrophobic cavity at the GP subunit interface and stabilizes GP, supporting an entry-blocking mechanism distinct from previously described GP-destabilizing inhibitors. In a lethal-challenge mouse model, MWAC-3634 administered either intraperitoneally or orally substantially improves survival and reduces clinical signs. These findings suggest that EBOV GP requires an optimal level of stability for entry, identify GP stabilization as an effective anti-filovirus strategy, and establish MWAC-3634 as a promising lead compound for development.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-77332-3","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:09:04Z","timestamp":1788275344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A small molecule inhibits Ebola virus entry through glycoprotein stabilization"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-3072","authenticated-orcid":false,"given":"Fan","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6034-2174","authenticated-orcid":false,"given":"Gang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran L.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugesan","family":"Palaniappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1445-8632","authenticated-orcid":false,"given":"Martin M.","family":"Matzuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-9658","authenticated-orcid":false,"given":"Damian W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Turner-Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5919-6746","authenticated-orcid":false,"given":"Kimberly","family":"Morsheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9972-1745","authenticated-orcid":false,"given":"Callum","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3154-4775","authenticated-orcid":false,"given":"Michael","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-2892","authenticated-orcid":false,"given":"Robert","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-4992","authenticated-orcid":false,"given":"Srinivas","family":"Chamakuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0081-3867","authenticated-orcid":false,"given":"Peter","family":"Dosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-366X","authenticated-orcid":false,"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"77332_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev-virology-092818-015708","volume":"6","author":"W Furuyama","year":"2019","unstructured":"Furuyama, W. & Marzi, A. Ebola virus: pathogenesis and countermeasure development. Annu. Rev. Virol. 6, 435\u2013458 https:\/\/doi.org\/10.1146\/annurev-virology-092818-015708 (2019).","journal-title":"Annu. Rev. Virol."},{"key":"77332_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","volume":"6","author":"ST Jacob","year":"2020","unstructured":"Jacob, S. T. et al. Ebola virus disease. Nat. Rev. Dis. Prim. 6, 13 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"77332_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1099\/jgv.0.001252","volume":"100","author":"JH Kuhn","year":"2019","unstructured":"Kuhn, J. H. et al. ICTV virus taxonomy profile: Filoviridae. J. Gen. Virol. 100, 911\u2013912 (2019).","journal-title":"J. Gen. Virol."},{"key":"77332_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1089\/vbz.2008.0167","volume":"9","author":"EM Leroy","year":"2009","unstructured":"Leroy, E. M. et al. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector-Borne Zoonotic Dis. 9, 723\u2013728 (2009).","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"77332_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi5229","volume":"14","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors. Sci. Transl. Med. 14, eabi5229 (2022).","journal-title":"Sci. Transl. Med."},{"key":"77332_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo, A. M. et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!). Lancet 389, 505\u2013518 https:\/\/doi.org\/10.1016\/s0140-6736(16)32621-6 (2017).","journal-title":"Lancet"},{"key":"77332_CR7","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","volume":"381","author":"S Mulangu","year":"2019","unstructured":"Mulangu, S. et al. A randomized, controlled trial of Ebola virus disease therapeutics. N. Engl. J. Med. 381, 2293\u20132303 https:\/\/doi.org\/10.1056\/NEJMoa1910993 (2019).","journal-title":"N. Engl. J. Med."},{"key":"77332_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-025-02766-y","volume":"22","author":"EM Kikwango","year":"2025","unstructured":"Kikwango, E. M., Akilimali, P. Z. & Tran, N. T. Impact of most promising Ebola therapies on survival: a secondary analysis during the tenth outbreak in the Democratic Republic of Congo. Virol. J. 22, 144 https:\/\/doi.org\/10.1186\/s12985-025-02766-y (2025).","journal-title":"Virol. J."},{"key":"77332_CR9","doi-asserted-by":"publisher","first-page":"e1010078","DOI":"10.1371\/journal.ppat.1010078","volume":"17","author":"C Woolsey","year":"2021","unstructured":"Woolsey, C. & Geisbert, T. W. Current state of Ebola virus vaccines: a snapshot. PLoS Pathog. 17, e1010078 https:\/\/doi.org\/10.1371\/journal.ppat.1010078 (2021).","journal-title":"PLoS Pathog."},{"key":"77332_CR10","doi-asserted-by":"publisher","unstructured":"Crozier, I. et al. The evolution of medical countermeasures for Ebola virus disease: lessons learned and next steps. Vaccines 10 https:\/\/doi.org\/10.3390\/vaccines10081213 (2022).","DOI":"10.3390\/vaccines10081213"},{"key":"77332_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adw0659","volume":"11","author":"C Woolsey","year":"2025","unstructured":"Woolsey, C. et al. The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection. Sci. Adv. 11, eadw0659 https:\/\/doi.org\/10.1126\/sciadv.adw0659 (2025).","journal-title":"Sci. Adv."},{"key":"77332_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren, T. K. et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531, 381\u2013385 https:\/\/doi.org\/10.1038\/nature17180 (2016).","journal-title":"Nature"},{"key":"77332_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature07082","volume":"454","author":"JE Lee","year":"2008","unstructured":"Lee, J. E. et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177\u2013182 (2008).","journal-title":"Nature"},{"key":"77332_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nsmb.1456","volume":"15","author":"SC Harrison","year":"2008","unstructured":"Harrison, S. C. Viral membrane fusion. Nat. Struct. Mol. Biol. 15, 690\u2013698 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77332_CR15","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.aad6117","volume":"351","author":"J Misasi","year":"2016","unstructured":"Misasi, J. et al. Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science 351, 1343\u20131346 (2016).","journal-title":"Science"},{"key":"77332_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2017.04.038","volume":"169","author":"X Zhao","year":"2017","unstructured":"Zhao, X. et al. Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability. Cell 169, 891\u2013904.e815 (2017).","journal-title":"Cell"},{"key":"77332_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001110","volume":"6","author":"MF Saeed","year":"2010","unstructured":"Saeed, M. F., Kolokoltsov, A. A., Albrecht, T. & Davey, R. A. Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 6, e1001110 https:\/\/doi.org\/10.1371\/journal.ppat.1001110 (2010).","journal-title":"PLoS Pathog."},{"key":"77332_CR18","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1110656","volume":"308","author":"K Chandran","year":"2005","unstructured":"Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P. & Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643\u20131645 (2005).","journal-title":"Science"},{"key":"77332_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature10348","volume":"477","author":"JE Carette","year":"2011","unstructured":"Carette, J. E. et al. Ebola virus entry requires the cholesterol transporter Niemann\u2013Pick C1. Nature 477, 340\u2013343 https:\/\/doi.org\/10.1038\/nature10348 (2011).","journal-title":"Nature"},{"key":"77332_CR20","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.cell.2016.05.022","volume":"165","author":"X Gong","year":"2016","unstructured":"Gong, X. et al. Structural insights into the Niemann-Pick C1 (NPC1)-mediated cholesterol transfer and Ebola infection. Cell 165, 1467\u20131478 https:\/\/doi.org\/10.1016\/j.cell.2016.05.022 (2016).","journal-title":"Cell"},{"key":"77332_CR21","doi-asserted-by":"publisher","first-page":"11211","DOI":"10.1073\/pnas.1104760108","volume":"108","author":"SM Gregory","year":"2011","unstructured":"Gregory, S. M. et al. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc. Natl. Acad. Sci. USA 108, 11211\u201311216 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77332_CR22","doi-asserted-by":"publisher","unstructured":"Spence, J. S., Krause, T. B., Mittler, E., Jangra, R. K. & Chandran, K. Direct visualization of Ebola virus fusion triggering in the endocytic pathway. MBio 7 https:\/\/doi.org\/10.1128\/mbio.01857-01815 (2016).","DOI":"10.1128\/mbio.01857-01815"},{"key":"77332_CR23","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1021\/acs.jmedchem.8b00035","volume":"61","author":"SJ Capuzzi","year":"2018","unstructured":"Capuzzi, S. J. et al. Computer-aided discovery and characterization of novel Ebola virus inhibitors. J. Med. Chem. 61, 3582\u20133594 https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00035 (2018).","journal-title":"J. Med. Chem."},{"key":"77332_CR24","doi-asserted-by":"publisher","first-page":"13737","DOI":"10.1021\/acs.jmedchem.4c00527","volume":"67","author":"D Durante","year":"2024","unstructured":"Durante, D. et al. N-substituted pyrrole-based heterocycles as broad-spectrum filoviral entry inhibitors. J. Med. Chem. 67, 13737\u201313764 https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00527 (2024).","journal-title":"J. Med. Chem."},{"key":"77332_CR25","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1021\/acs.jmedchem.2c01785","volume":"66","author":"A Garcia-Rubia","year":"2023","unstructured":"Garcia-Rubia, A. et al. N\u2019-phenylacetohydrazide derivatives as potent Ebola virus entry inhibitors with an improved pharmacokinetic profile. J. Med. Chem. 66, 5465\u20135483 https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01785 (2023).","journal-title":"J. Med. Chem."},{"key":"77332_CR26","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.1021\/acs.jmedchem.0c00463","volume":"63","author":"IN Gaisina","year":"2020","unstructured":"Gaisina, I. N. et al. Discovery and structural optimization of 4-(Aminomethyl)benzamides as potent entry inhibitors of Ebola and Marburg virus infections. J. Med. Chem. 63, 7211\u20137225 https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00463 (2020).","journal-title":"J. Med. Chem."},{"key":"77332_CR27","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1021\/acs.jmedchem.8b01328","volume":"62","author":"F Shaikh","year":"2019","unstructured":"Shaikh, F. et al. Structure-based in silico screening identifies a potent ebolavirus inhibitor from a traditional chinese medicine library. J. Med. Chem. 62, 2928\u20132937 https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01328 (2019).","journal-title":"J. Med. Chem."},{"key":"77332_CR28","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1021\/acs.jmedchem.0c01001","volume":"63","author":"L Cooper","year":"2020","unstructured":"Cooper, L. et al. Screening and reverse-engineering of estrogen receptor ligands as potent pan-filovirus inhibitors. J. Med. Chem. 63, 11085\u201311099 https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01001 (2020).","journal-title":"J. Med. Chem."},{"key":"77332_CR29","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1021\/acs.jmedchem.7b01249","volume":"61","author":"J Ren","year":"2018","unstructured":"Ren, J., Zhao, Y., Fry, E. E. & Stuart, D. I. Target identification and mode of action of four chemically divergent drugs against ebolavirus infection. J. Med. Chem. 61, 724\u2013733 https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01249 (2018).","journal-title":"J. Med. Chem."},{"key":"77332_CR30","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1021\/acs.jmedchem.8b00350","volume":"61","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. Structures of Ebola virus glycoprotein complexes with tricyclic antidepressant and antipsychotic drugs. J. Med. Chem. 61, 4938\u20134945 https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00350 (2018).","journal-title":"J. Med. Chem."},{"key":"77332_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature18615","volume":"535","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y. et al. Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature 535, 169\u2013172 https:\/\/doi.org\/10.1038\/nature18615 (2016).","journal-title":"Nature"},{"key":"77332_CR32","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1128\/aac.00070-15","volume":"59","author":"C Arico-Muendel","year":"2015","unstructured":"Arico-Muendel, C. et al. Encoded library technology screening of hepatitis C virus NS4B yields a small-molecule compound series with in vitro replicon activity. Antimicrob. Agents Chemother. 59, 3450\u20133459 https:\/\/doi.org\/10.1128\/aac.00070-15 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"77332_CR33","doi-asserted-by":"publisher","unstructured":"Chamakuri, S. et al. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M(pro) inhibitors. Proc. Natl. Acad. Sci. USA 118 https:\/\/doi.org\/10.1073\/pnas.2111172118 (2021).","DOI":"10.1073\/pnas.2111172118"},{"key":"77332_CR34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s42004-023-00961-y","volume":"6","author":"R Jimmidi","year":"2023","unstructured":"Jimmidi, R. et al. DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors. Commun. Chem. 6, 164 https:\/\/doi.org\/10.1038\/s42004-023-00961-y (2023).","journal-title":"Commun. Chem."},{"key":"77332_CR35","doi-asserted-by":"publisher","first-page":"33983","DOI":"10.1021\/jacs.4c12992","volume":"146","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Covalent DNA-encoded library workflow drives discovery of SARS-CoV-2 nonstructural protein inhibitors. J. Am. Chem. Soc. 146, 33983\u201333996 https:\/\/doi.org\/10.1021\/jacs.4c12992 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"77332_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1126\/science.adl2688","volume":"384","author":"AF Ku","year":"2024","unstructured":"Ku, A. F. et al. Reversible male contraception by targeted inhibition of serine\/threonine kinase 33. Science 384, 885\u2013890 https:\/\/doi.org\/10.1126\/science.adl2688 (2024).","journal-title":"Science"},{"key":"77332_CR37","doi-asserted-by":"publisher","first-page":"e1012817","DOI":"10.1371\/journal.ppat.1012817","volume":"20","author":"F Bu","year":"2024","unstructured":"Bu, F. et al. Discovery of nanosota-EB1 and -EB2 as novel nanobody inhibitors against Ebola virus infection. PLoS Pathog. 20, e1012817 https:\/\/doi.org\/10.1371\/journal.ppat.1012817 (2024).","journal-title":"PLoS Pathog."},{"key":"77332_CR38","doi-asserted-by":"publisher","first-page":"9958","DOI":"10.1021\/ja052935r","volume":"127","author":"DA Evans","year":"2005","unstructured":"Evans, D. A. & Seidel, D. Ni(II)\u2212Bis[(R,R)-N,N\u2018-dibenzylcyclohexane-1,2-diamine]Br2 catalyzed enantioselective Michael additions of 1,3-dicarbonyl compounds to conjugated nitroalkenes. J. Am. Chem. Soc. 127, 9958\u20139959 https:\/\/doi.org\/10.1021\/ja052935r (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"77332_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013878","volume":"22","author":"F Bu","year":"2026","unstructured":"Bu, F. et al. A highly potent and broadly accessible bispecific nanobody for the treatment of Ebola virus infections. PLoS Pathog. 22, e1013878 https:\/\/doi.org\/10.1371\/journal.ppat.1013878 (2026).","journal-title":"PLoS Pathog."},{"key":"77332_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06113-4","volume":"9","author":"BM Janus","year":"2018","unstructured":"Janus, B. M. et al. Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop. Nat. Commun. 9, 3934 https:\/\/doi.org\/10.1038\/s41467-018-06113-4 (2018).","journal-title":"Nat. Commun."},{"key":"77332_CR41","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1172\/jci83111","volume":"125","author":"S Lanini","year":"2015","unstructured":"Lanini, S. et al. Blood kinetics of Ebola virus in survivors and nonsurvivors.  J. Clin. Investig. 125, 4692\u20134698 https:\/\/doi.org\/10.1172\/jci83111 (2015).","journal-title":"J. Clin. Investig."},{"key":"77332_CR42","doi-asserted-by":"publisher","unstructured":"Alfson, K. J. et al. Development of a well-characterized rhesus macaque model of Ebola virus disease for support of product development. Microorganisms 9 https:\/\/doi.org\/10.3390\/microorganisms9030489 (2021).","DOI":"10.3390\/microorganisms9030489"},{"key":"77332_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008375","volume":"16","author":"LE Liao","year":"2020","unstructured":"Liao, L. E. et al. Quantification of Ebola virus replication kinetics in vitro. PLoS Comput Biol. 16, e1008375 https:\/\/doi.org\/10.1371\/journal.pcbi.1008375 (2020).","journal-title":"PLoS Comput Biol."},{"key":"77332_CR44","doi-asserted-by":"publisher","unstructured":"Finch, C. L. et al. Formulation, stability, pharmacokinetic, and modeling studies for tests of synergistic combinations of orally available approved drugs against Ebola virus in vivo. Microorganisms 9 https:\/\/doi.org\/10.3390\/microorganisms9030566 (2021).","DOI":"10.3390\/microorganisms9030566"},{"key":"77332_CR45","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Toremifene. In Some Pharmaceutical Drugs (ed. Cheney, J.) (International Agency for Research on Cancer, 1996)."},{"key":"77332_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s42003-025-07613-y","volume":"8","author":"F Bu","year":"2025","unstructured":"Bu, F. et al. Cryo-EM structure of Sudan ebolavirus glycoprotein complexed with its human endosomal receptor NPC1. Commun. Biol. 8, 156 https:\/\/doi.org\/10.1038\/s42003-025-07613-y (2025).","journal-title":"Commun. Biol."},{"key":"77332_CR47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41586-026-10240-0","volume":"653","author":"G Ye","year":"2026","unstructured":"Ye, G. et al. Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor. Nature 653, 621\u2013626 https:\/\/doi.org\/10.1038\/s41586-026-10240-0 (2026).","journal-title":"Nature"},{"key":"77332_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1126\/science.abd3255","volume":"370","author":"C Toelzer","year":"2020","unstructured":"Toelzer, C. et al. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science 370, 725\u2013730 https:\/\/doi.org\/10.1126\/science.abd3255 (2020).","journal-title":"Science"},{"key":"77332_CR49","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1073\/pnas.1222379110","volume":"110","author":"P Plevka","year":"2013","unstructured":"Plevka, P. et al. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc. Natl. Acad. Sci. USA 110, 5463\u20135467 https:\/\/doi.org\/10.1073\/pnas.1222379110 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77332_CR50","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.ppat.0020073","volume":"2","author":"H Ebihara","year":"2006","unstructured":"Ebihara, H. et al. Molecular determinants of Ebola virus virulence in mice. PLoS Pathog. 2, e73 https:\/\/doi.org\/10.1371\/journal.ppat.0020073 (2006).","journal-title":"PLoS Pathog."},{"key":"77332_CR51","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 https:\/\/doi.org\/10.1038\/nmeth.4169 (2017).","journal-title":"Nat. Methods"},{"key":"77332_CR52","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jsb.2015.08.007","volume":"192","author":"JL Rubinstein","year":"2015","unstructured":"Rubinstein, J. L. & Brubaker, M. A. Alignment of cryo-EM movies of individual particles by optimization of image translations. J. Struct. Biol. 192, 188\u2013195 https:\/\/doi.org\/10.1016\/j.jsb.2015.08.007 (2015).","journal-title":"J. Struct. Biol."},{"key":"77332_CR53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 https:\/\/doi.org\/10.1016\/j.jsb.2015.08.008 (2015).","journal-title":"J. Struct. Biol."},{"key":"77332_CR54","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D: Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"77332_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D: Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"77332_CR56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"77332_CR57","doi-asserted-by":"publisher","unstructured":"Keiser, P. T., Anantpadma, M., Staples, H., Carrion, R. & Davey, R. A. Automation of infectious focus assay for determination of filovirus titers and direct comparison to plaque and TCID(50) assays. Microorganisms 9 https:\/\/doi.org\/10.3390\/microorganisms9010156 (2021).","DOI":"10.3390\/microorganisms9010156"},{"key":"77332_CR58","doi-asserted-by":"publisher","first-page":"S248","DOI":"10.1086\/514292","volume":"179","author":"M Bray","year":"1999","unstructured":"Bray, M., Davis, K., Geisbert, T., Schmaljohn, C. & Huggins, J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 179, S248\u2013S258 https:\/\/doi.org\/10.1086\/514292 (1999).","journal-title":"J. Infect. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77332-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77332-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77332-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:08:31Z","timestamp":1790867311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77332-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77332"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77332-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Minnesota has filed patents on MWAC-2600, 2601, 2807, 2808, 3006, 3634, and 4219 with F.L., P.D., F.B., G.Y., M.M.M., D.W.Y., S.C., and M.P. as inventors. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10401"}}